Apellis Pharmaceuticals Ownership | Who Owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Ownership Summary
Apellis Pharmaceuticals is owned by 94.49% institutional investors, 13.98% insiders. Wellington management group llp is the largest institutional shareholder, holding 13.33% of APLS shares. Vanguard Health Care Inv is the top mutual fund, with 8.29% of its assets in Apellis Pharmaceuticals shares.
APLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Apellis Pharmaceuticals | 94.49% | 13.98% | -8.47% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Wellington management group llp | 16.39M | 13.33% | $628.67M |
| Ecor1 capital | 11.61M | 9.37% | $445.26M |
| Avoro capital advisors | 11.11M | 8.97% | $426.22M |
| Vanguard group | 9.81M | 7.98% | $376.29M |
| Blackrock | 5.80M | 4.71% | $222.31M |
| State street | 4.15M | 3.37% | $159.07M |
| T. rowe price investment management | 4.05M | 3.27% | $155.30M |
| Fmr | 3.30M | 2.68% | $126.58M |
| Jpmorgan chase | 3.18M | 2.58% | $121.89M |
| Jennison associates | 2.76M | 2.23% | $88.08M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ecor1 capital | 11.61M | 13.62% | $445.26M |
| Avoro capital advisors | 11.11M | 5.68% | $426.22M |
| Boxer capital | 1.73M | 3.49% | $66.21M |
| Deep track capital, lp | 2.50M | 2.86% | $95.90M |
| Octagon capital advisors lp | 350.00K | 2.11% | $13.43M |
| Ghost tree capital | 135.00K | 1.62% | $5.18M |
| Exome asset management | 46.90K | 1.60% | $1.80M |
| Artal group | 1.47M | 1.43% | $56.28M |
| Braidwell lp | 611.80K | 0.74% | $23.47M |
| 683 capital management | 186.00K | 0.54% | $7.13M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 2.50M | 2.86% | 1.50M |
| Wellington management group llp | 16.39M | 0.11% | 1.33M |
| State street | 4.15M | 0.01% | 1.24M |
| Fmr | 3.30M | 0.01% | 1.12M |
| Norges bank | 1.08M | 0.01% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Assenagon asset management | 29.99K | 0.00% | -2.11M |
| Fiera capital | - | - | -1.35M |
| Price t rowe associates inc /md/ | 1.28M | 0.01% | -1.18M |
| Citadel advisors | 153.89K | 0.00% | -1.03M |
| Frazier life sciences management | - | - | -885.16K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.08M | 0.01% | 1.08M | $41.41M |
| Voloridge investment management | 689.11K | 0.10% | 689.11K | $26.43M |
| Braidwell lp | 611.80K | 0.74% | 611.80K | $23.47M |
| Capital fund management | 201.49K | 0.02% | 201.49K | $7.73M |
| Rock springs capital management lp | 140.70K | 0.16% | 140.70K | $5.40M |
Sold Out
| Holder | Change |
|---|---|
| Concourse financial group securities | -1.00 |
| Jfs wealth advisors | -1.00 |
| Quest partners | -1.00 |
| Fortitude family office | -6.00 |
| Avion wealth | -18.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 291 | 2.46% | 117,076,868 | 1.49% | 94 | 1.09% | 142 | -12.35% | 93 | 43.08% |
| Jun 30, 2024 | 284 | -13.41% | 115,360,815 | 2.98% | 93 | 1.12% | 162 | -2.41% | 65 | -32.29% |
| Mar 31, 2024 | 328 | -0.30% | 112,027,605 | -1.51% | 91 | 0.99% | 166 | 14.48% | 96 | -14.29% |
| Dec 31, 2023 | 329 | 7.52% | 113,740,832 | 0.83% | 95 | 1.09% | 145 | -15.20% | 112 | 64.71% |
| Sep 30, 2023 | 306 | -14.76% | 112,801,177 | 5.80% | 93 | 1.17% | 171 | -0.58% | 68 | -44.26% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 10.09M | 8.29% | 585.23K |
| Vanguard Total Stock Mkt Idx Inv | 3.30M | 2.65% | 37.08K |
| SPDR® S&P Biotech ETF | 2.75M | 2.21% | -32.14K |
| Vanguard Small Cap Index | 2.69M | 2.16% | 81.88K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.65M | 1.32% | 70.42K |
| Vanguard Small Cap Growth Index Inv | 1.53M | 1.23% | 92.64K |
| Polar Capital Biotech S Inc | 1.50M | 1.21% | 500.00K |
| JPM US Mid Cap Growth-Composite | 1.30M | 1.07% | 294.66K |
| DWS Vermögensbildungsfonds I LD | 1.32M | 1.06% | -3.00 |
| JPMorgan Mid Cap Growth I | 1.30M | 1.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 22, 2025 | Watson David O. | General Counsel | Sell | $101.10K |
| Jan 22, 2025 | Townsend Adam J. | Chief Commercial Officer | Sell | $101.10K |
| Jan 22, 2025 | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $93.95K |
| Jan 22, 2025 | Nicholson Nur | Chief Technical Officer | Sell | $120.12K |
| Jan 22, 2025 | Lewis Karen | Chief People Officer | Sell | $53.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 4 |
| 2024 Q2 | - | 8 |
| 2024 Q1 | - | 57 |
| 2023 Q4 | - | 19 |
APLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools